MA28871B1 - Derives tricycliques accoles pour le traitement de troubles psychotiques - Google Patents

Derives tricycliques accoles pour le traitement de troubles psychotiques

Info

Publication number: MA28871B1
Authority: MA; Morocco
Prior art keywords: accurate; treatment; psychotic disorders; tricyclic derivatives; tricyclic
Prior art date: 2004-08-31

Application number

MA29771A

Other languages

English (en)

Inventor

Jonathan Bentley

Markus Bergauer

Barbara Bertani

Matteo Biagetti

Manuela Borriello

Steven Mark Bromidge

Massimo Gianotti

Enrica Granci

Colin Philip Leslie

Alessandra Pasquarello

Valeria Zucchelli

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-31

Filing date

2007-03-23

Publication date

2007-09-03

2004-08-31 Priority claimed from GB0419315A external-priority patent/GB0419315D0/en

2005-04-12 Priority claimed from GB0507386A external-priority patent/GB0507386D0/en

2005-07-21 Priority claimed from GB0515010A external-priority patent/GB0515010D0/en

2007-03-23 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2007-09-03 Publication of MA28871B1 publication Critical patent/MA28871B1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA29771A 2004-08-31 2007-03-23 Derives tricycliques accoles pour le traitement de troubles psychotiques MA28871B1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0419315A GB0419315D0 (en)	2004-08-31	2004-08-31	Compounds
GB0507386A GB0507386D0 (en)	2005-04-12	2005-04-12	Compounds
GB0515010A GB0515010D0 (en)	2005-07-21	2005-07-21	Compounds

Publications (1)

Publication Number	Publication Date
MA28871B1 true MA28871B1 (fr)	2007-09-03

Family

ID=35106764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29771A MA28871B1 (fr)	2004-08-31	2007-03-23	Derives tricycliques accoles pour le traitement de troubles psychotiques

Country Status (17)

Country	Link
US (1)	US20120022056A1 (fr)
EP (1)	EP1786822A1 (fr)
JP (1)	JP2008511574A (fr)
KR (1)	KR20070057885A (fr)
CN (1)	CN101048414B (fr)
AR (1)	AR053307A1 (fr)
AU (1)	AU2005279278A1 (fr)
BR (1)	BRPI0514377A (fr)
CA (1)	CA2578781A1 (fr)
IL (1)	IL181387A (fr)
MA (1)	MA28871B1 (fr)
MX (1)	MX2007002548A (fr)
NO (1)	NO20071326L (fr)
NZ (1)	NZ553506A (fr)
PE (1)	PE20060653A1 (fr)
TW (1)	TW200619221A (fr)
WO (1)	WO2006024517A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0316915D0 (en)	2003-07-18	2003-08-20	Glaxo Group Ltd	Compounds
US7898642B2 (en)	2004-04-14	2011-03-01	Asml Netherlands B.V.	Lithographic apparatus and device manufacturing method
CN101296914B (zh) *	2005-08-26	2012-07-18	盐野义制药株式会社	具有ppar激动活性的衍生物
JP2009523820A (ja) *	2006-01-23	2009-06-25	アミラファーマシューティカルス，インコーポレーテッド	５−リポキシゲナーゼの三環系抑制剤
WO2008005908A2 (fr)	2006-07-07	2008-01-10	Forest Laboratories Holdings Limited	Dérivés de pyridoïmidazole
ES2498519T3 (es)	2006-09-07	2014-09-24	F. Hoffmann-La Roche Ag	Un procedimiento para la fabricación de SNAC (SALCAPROZATO SÓDICO)
JP2010504367A (ja)	2006-09-26	2010-02-12	グラクソグループリミテッド	性機能障害、認知障害、精神病性障害、不安、鬱病などを処置するための５ｈｔ１ａ受容体モジュレーターとしての５−｛２−［４−（２−メチル−５−キノリニル）−ｌ−ピペリジニル］エチル｝キノリノン誘導体
US7691851B2 (en) *	2007-03-07	2010-04-06	Alantos Pharmaceuticals Holding, Inc.	Metalloprotease inhibitors containing a heterocyclic moiety
EP2070933A1 (fr)	2007-12-07	2009-06-17	Laboratorios del Dr. Esteve S.A.	Composants triazoliques tricycliques
GB0800840D0 (en)	2008-01-17	2008-02-27	Glaxo Group Ltd	Novel salt
PL2268644T3 (pl)	2008-03-05	2012-01-31	Boehringer Ingelheim Int	Tricykliczne pochodne piperydyny, leki zawierające te związki, ich zastosowanie i sposoby ich wytwarzania
WO2010111626A2 (fr) *	2009-03-27	2010-09-30	Takeda Pharmaceutical Company Limited	Inhibiteurs de la poly(adp-ribose)polymérase (parp)
AP2012006390A0 (en)	2010-02-19	2012-08-31	Boehringer Ingelheim Int	Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
SG186885A1 (en)	2010-06-04	2013-02-28	Albany Molecular Res Inc	Glycine transporter-1 inhibitors, methods of making them, and uses thereof
WO2012154731A1 (fr) *	2011-05-08	2012-11-15	Vanderbilt University	Analogues de 1h-pyrrolo[3,2-c]quinoléine-4(5h)-one substitués utilisés comme modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4
US9150583B2 (en)	2011-08-17	2015-10-06	Boehringer Ingelheim International Gmbh	Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
EP2792679A1 (fr) *	2013-04-19	2014-10-22	Laboratorios Del. Dr. Esteve, S.A.	Composants triazoliques tricycliques
EP3013823B1 (fr)	2013-06-24	2017-11-01	Merck Patent GmbH	Composés imidazole servant de modulateurs des récepteurs de la fshr et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9706196A (es) *	1996-08-14	1998-02-28	Pfizer	Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p.
IL124914A (en) *	1997-06-26	2000-10-31	Akzo Nobel Nv	Pharmaceutical compositions containing 6-aryl-2,3,5,6-tetrahydroimidazo¬2,1-a¾isoquinoline derivatives and some new such compounds
US6919334B2 (en) *	2002-09-12	2005-07-19	Wyeth	Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
GB0227240D0 (en) *	2002-11-21	2002-12-31	Glaxo Group Ltd	Compounds

2005
- 2005-08-26 PE PE2005000983A patent/PE20060653A1/es not_active Application Discontinuation
- 2005-08-29 KR KR1020077007190A patent/KR20070057885A/ko not_active Ceased
- 2005-08-29 US US11/574,450 patent/US20120022056A1/en not_active Abandoned
- 2005-08-29 BR BRPI0514377-2A patent/BRPI0514377A/pt not_active IP Right Cessation
- 2005-08-29 AU AU2005279278A patent/AU2005279278A1/en not_active Abandoned
- 2005-08-29 TW TW094129416A patent/TW200619221A/zh unknown
- 2005-08-29 CA CA002578781A patent/CA2578781A1/fr not_active Abandoned
- 2005-08-29 EP EP05778196A patent/EP1786822A1/fr not_active Withdrawn
- 2005-08-29 AR ARP050103607A patent/AR053307A1/es not_active Application Discontinuation
- 2005-08-29 MX MX2007002548A patent/MX2007002548A/es active IP Right Grant
- 2005-08-29 CN CN2005800372427A patent/CN101048414B/zh not_active Expired - Fee Related
- 2005-08-29 NZ NZ553506A patent/NZ553506A/en not_active IP Right Cessation
- 2005-08-29 JP JP2007528777A patent/JP2008511574A/ja active Pending
- 2005-08-29 WO PCT/EP2005/009379 patent/WO2006024517A1/fr not_active Ceased
2007
- 2007-02-15 IL IL181387A patent/IL181387A/en not_active IP Right Cessation
- 2007-03-12 NO NO20071326A patent/NO20071326L/no not_active Application Discontinuation
- 2007-03-23 MA MA29771A patent/MA28871B1/fr unknown

Also Published As

Publication number	Publication date
WO2006024517A1 (fr)	2006-03-09
KR20070057885A (ko)	2007-06-07
IL181387A (en)	2011-10-31
US20120022056A1 (en)	2012-01-26
JP2008511574A (ja)	2008-04-17
TW200619221A (en)	2006-06-16
EP1786822A1 (fr)	2007-05-23
CN101048414B (zh)	2011-09-07
AR053307A1 (es)	2007-05-02
CA2578781A1 (fr)	2006-03-09
CN101048414A (zh)	2007-10-03
NZ553506A (en)	2010-02-26
IL181387A0 (en)	2007-07-04
MX2007002548A (es)	2007-04-24
AU2005279278A1 (en)	2006-03-09
PE20060653A1 (es)	2006-09-27
NO20071326L (no)	2007-05-03
BRPI0514377A (pt)	2008-06-24

Publication	Publication Date	Title
MA28871B1 (fr)	2007-09-03	Derives tricycliques accoles pour le traitement de troubles psychotiques
MA28791B1 (fr)	2007-08-01	Derives de piperazine convenant pour le traitement de troubles gastro-intestinaux
MA28555B1 (fr)	2007-04-03	Derives de morpholine substitues pour le traitement de troubles du systeme nerveux central
MA28481B1 (fr)	2007-03-01	Dérivés d'imidazole pour le traitement de troubles neurodégénératifs
EP2096919A4 (fr)	2010-11-17	Produits dérivés de 2,3-dihydroimidazo[1,2-c]quinazoline substitués, utiles pour le traitement de troubles hyperlifératifs et de maladies associées à une angiogénèse
FR13C0029I2 (fr)	2024-04-19	Compositions pour le traitement de troubles gastro-intestinaux
EP2063889A4 (fr)	2009-09-16	Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer
CY2018028I1 (el)	2019-07-10	Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων
EP1601251A4 (fr)	2007-03-28	Compos s pour le traitement de troubles m taboliques
EP1931691A4 (fr)	2012-01-11	Inhibiteurs d'odcase pour le traitement du paludisme
ZA200801888B (en)	2009-07-29	Derivatives of 4-piperazin-1-1-YL-4-benzo [B] thiophene suitable for the treatment of CNS disorders
ZA200700384B (en)	2008-09-25	Hydantoin derivatives for the treatment of inflammatory disorders
DK1474416T3 (da)	2008-01-14	Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
IS2907B (is)	2014-11-15	Bensó[d]asepínafleiður til að meðhöndla taugakvilla
DK1592384T3 (da)	2012-12-17	Cop 1 til behandling af inflammatoriske tarmsygdomme
DK2418201T3 (da)	2014-05-12	Polymorfe former af (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin) yl]-4-penten-2-amin p-hydroxybenzoat til behandling af centralnervesystemlidelser
EP1758854A4 (fr)	2007-12-19	Composes pyrrolidin-3-yle utiles en tant qu'inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
EP1804787A4 (fr)	2009-01-14	Composition flavonoide pour le traitement des maladies bucco-dentaires
EP2225196A4 (fr)	2012-02-29	Inhibiteurs de cystéine-protéases pour le traitement de maladies parasitaires
EP1933813A4 (fr)	2013-02-27	Liposomes de sphingomyeline pour le traitement de troubles de vessie hyperactive
EP1814537A4 (fr)	2009-09-16	Inhibiteurs de la beta-secretase formes d'amines tertiaires macrocycliques pour le traitement de la maladie d'alzheimer
EP1855682A4 (fr)	2008-05-07	Formes posologiques d'aminopterine et methodes pour troubles inflammatoires
EP2015741A4 (fr)	2009-12-23	Inhibiteurs de l'histone desacétylase pour le traitement de la neurodégénération
EP1752464A4 (fr)	2011-06-01	Procede de preparation de timosaponine b ii
MA28493B1 (fr)	2007-03-01	Sulfonamides destinés au traitement de troubles neurodégénératifs